Krarup-Hansen A - Search Results

1

Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison.

Iida H, Law I, Pakkenberg B, Krarup-Hansen A, Eberl S, Holm S, Hansen AK, Gundersen HJ, Thomsen C, Svarer C, Ring P, Friberg L, Paulson OB. Iida H, et al. J Cereb Blood Flow Metab. 2000 Aug;20(8):1237-51. doi: 10.1097/00004647-200008000-00009. J Cereb Blood Flow Metab. 2000. PMID: 10950386

2

Chemotherapy in malignant mesothelioma: a review.

Krarup-Hansen A, Hansen HH. Krarup-Hansen A, et al. Cancer Chemother Pharmacol. 1991;28(5):319-30. doi: 10.1007/BF00685684. Cancer Chemother Pharmacol. 1991. PMID: 1914074 Review.

3

Ifosfamide in malignant mesothelioma: a phase II study.

Andersen MK, Krarup-Hansen A, Mårtensson G, Winther-Nielsen H, Thylen A, Damgaard K, Olling S, Wallin J. Andersen MK, et al. Lung Cancer. 1999 Apr;24(1):39-43. doi: 10.1016/s0169-5002(99)00030-6. Lung Cancer. 1999. PMID: 10403693 Clinical Trial.

4

Dosimetric and geometric evaluation of an open low-field magnetic resonance simulator for radiotherapy treatment planning of brain tumours.

Kristensen BH, Laursen FJ, Løgager V, Geertsen PF, Krarup-Hansen A. Kristensen BH, et al. Radiother Oncol. 2008 Apr;87(1):100-9. doi: 10.1016/j.radonc.2008.01.014. Epub 2008 Feb 11. Radiother Oncol. 2008. PMID: 18262669

5

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Judson I, et al. Lancet Oncol. 2014 Apr;15(4):415-23. doi: 10.1016/S1470-2045(14)70063-4. Epub 2014 Mar 5. Lancet Oncol. 2014. PMID: 24618336 Clinical Trial.

6

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.

Blay JY, Schöffski P, Bauer S, Krarup-Hansen A, Benson C, D'Adamo DR, Jia Y, Maki RG. Blay JY, et al. Br J Cancer. 2019 May;120(11):1026-1032. doi: 10.1038/s41416-019-0462-1. Epub 2019 May 8. Br J Cancer. 2019. PMID: 31065111 Free PMC article. Clinical Trial.

7

Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study.

Kristensen B, Ejlertsen B, Holmegaard SN, Krarup-Hansen A, Transbøl I, Mouridsen H. Kristensen B, et al. J Intern Med. 1992 Sep;232(3):237-45. doi: 10.1111/j.1365-2796.1992.tb00578.x. J Intern Med. 1992. PMID: 1402620 Clinical Trial.

8

Extra-visceral soft tissue sarcomas in adults: local treatment with special reference to irradiation.

Krarup-Hansen A, Poulsen HS. Krarup-Hansen A, et al. Cancer Treat Rev. 1989 Dec;16(4):221-46. doi: 10.1016/0305-7372(89)90043-1. Cancer Treat Rev. 1989. PMID: 2700317 Review. No abstract available.

9

Phase I study of 4-demethoxydaunorubicin by oral route in patients with advanced cancer.

Krarup-Hansen A, Andersen E, Elbaek K, Rasmussen SN, Dalmark M. Krarup-Hansen A, et al. Acta Oncol. 1988;27(5):521-5. doi: 10.3109/02841868809093581. Acta Oncol. 1988. PMID: 3203009

10

Pharmacokinetics of doxorubicin in man with induced acid or alkaline urine.

Krarup-Hansen A, Wassermann K, Rasmussen SN, Dalmark M. Krarup-Hansen A, et al. Acta Oncol. 1988;27(1):25-30. doi: 10.3109/02841868809090314. Acta Oncol. 1988. PMID: 3365351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters